Pfizer arm buys Bharti Healthcare for Rs 88 cr

Capsugel, he said, will bring world-class manufacturing practices and quality standards for meeting the requirements of existing and future customers. ‘‘The worldwide presence of Capsugel coupled with its marketing strengths would result in further exposure to new clients.’’

The company has, however, said that in compliance with the undertaking furnished, pursuant to Sebi delisting guidelines, by the promoters to BSE, the promoters will continue to buy the shares from other shareholders at Rs 83 per share for 6 months from October 11, 2005 (delisting date).

According to Pfizer, ‘‘In considering opportunities to enter the Indian market, Pfizer selected Bharti Healthcare Ltd based on the strong results and reputation built up by the leadership of Bharti. We are very excited about this opportunity and look forward to a successful future in India.’’ The Bharti Healthcare plant, located in Dharuhera, Haryana, produces capsules of various sizes, ranging from ’00’ to ’4’. Production takes place on high-speed fully automatic machines imported from the US thus ensuring the highest standards of production and quality, company officials said.